314

Sipai Health Technology Co., Ltd. Stock Price

SEHK:314 Community·HK$2.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

314 Share Price Performance

HK$3.24
-2.80 (-46.36%)
HK$3.24
-2.80 (-46.36%)
Price HK$3.24

314 Community Narratives

There are no narratives available yet.

Recent 314 News & Updates

Sipai Health Technology Co., Ltd.'s (HKG:314) Shares Climb 25% But Its Business Is Yet to Catch Up

Aug 04
Sipai Health Technology Co., Ltd.'s (HKG:314) Shares Climb 25% But Its Business Is Yet to Catch Up

We Think Sipai Health Technology (HKG:314) Can Easily Afford To Drive Business Growth

Jul 18
We Think Sipai Health Technology (HKG:314) Can Easily Afford To Drive Business Growth

Investors Appear Satisfied With Sipai Health Technology Co., Ltd.'s (HKG:314) Prospects As Shares Rocket 31%

Jun 18
Investors Appear Satisfied With Sipai Health Technology Co., Ltd.'s (HKG:314) Prospects As Shares Rocket 31%

Sipai Health Technology Co., Ltd.'s (HKG:314) 32% Cheaper Price Remains In Tune With Revenues

Apr 18
Sipai Health Technology Co., Ltd.'s (HKG:314) 32% Cheaper Price Remains In Tune With Revenues

Sipai Health Technology Co., Ltd. Key Details

CN¥3.4b

Revenue

CN¥3.1b

Cost of Revenue

CN¥332.7m

Gross Profit

CN¥650.2m

Other Expenses

-CN¥317.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.42
Gross Margin
9.71%
Net Profit Margin
-9.27%
Debt/Equity Ratio
0%

Sipai Health Technology Co., Ltd. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet and fair value.

1 Risk
2 Rewards

About 314

Founded
2014
Employees
2950
CEO
Xuguang Ma
WebsiteView website
www.medbankshealthtech.com

Sipai Health Technology Co., Ltd. operates as a medical technology and health management company in the People’s Republic of China. The company operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Health Insurance Services Business. The Specialty Pharmacy Business segment provides specialty pharmacies and value-added professional pharmacist services; focuses on innovative medicines for the treatment of oncology; pharmaceutical supply chain network for health insurance services; and other critical illnesses. The Physician Research Assistance Business segment offers pharmaceutical companies and other clinical trial institutions site management organization services, including site feasibility, site initiation, patient recruitment, patient management, data entry and document management, on-site drug management and bio-sample management, site closure, and others; and services for image management in clinical trials. The Health Insurance Services Business segment provides insurance brokerage services to insurance companies; and health management services to insurance carriers and enterprise clients. The company was founded in 2014 and is headquartered in Putuo, the People’s Republic of China.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Chinese Market Performance

  • 7 Days: 1.8%
  • 3 Months: 18.3%
  • 1 Year: 24.1%
  • Year to Date: 26.2%
The Industrials sector has led the market, which has gained 1.8%. In the last year, the market has climbed 24%. Earnings are forecast to grow by 27% annually. Market details ›